We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alzheimer’s Drugs Should Be No More Than $3,000 Per Year to Be Cost-Effective, Study Says
Alzheimer’s Drugs Should Be No More Than $3,000 Per Year to Be Cost-Effective, Study Says
In order to be cost-effective relative to standard Alzheimer’s care, Aduhelm — the newly approved Alzheimer’s antibody — would have to cost no more than $3,000 per year, rather than the current $56,000 price tag.